Sectors
CNTX
Context Therapeutics Inc.
0.63
4 x 0.63
4 x 0.63
bid
ask
-
0.00
0.19%
01:07 PM
timesize
| Ytd | -57.22% | |
| 1y | -23.98% |
0.62
day range
0.65
0.55
52 week range
3.62
| Open | 0.63 | Prev Close | 0.63 | Low | 0.62 | High | 0.65 | Mkt Cap | 57.88M |
| Vol | 893.82K | Avg Vol | 2.27M | EPS | -0.42 | P/E | -1.50 | Forward P/E | -3.38 |
| Beta | 1.75 | Short Ratio | 2.79 | Inst. Own | 76.40% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-07 | 50-d Avg | 1.42 | 200-d Avg | 1.75 | 1yr Est | 7.70 |
| Income Statement | |||
| Operating Expenses | 9.20M | ||
| Research and Development Expense | 7.02M | ||
| Selling, General and Administrative Expense | 2.33M | ||
| Operating Income | -9.20M | ||
| Net Income | -8.68M | ||
| Net Income Common Stock | -8.68M | ||
| Net Income Common Stock (USD) | -8.68M | ||
| Consolidated Income | -8.68M | ||
| Earnings per Basic Share | -0.09 | ||
| Earnings per Basic Share (USD) | -0.09 | ||
| Earnings per Diluted Share | -0.09 | ||
| Earning Before Interest & Taxes (EBIT) | -8.68M | ||
| Earning Before Interest & Taxes (USD) | -8.68M | ||
| Weighted Average Shares | 95.18M | ||
| Weighted Average Shares Diluted | 95.18M | ||
| Balance Sheet | |||
| Cash and Equivalents | 54.53M | ||
| Cash and Equivalents (USD) | 54.53M | ||
| Current Assets | 58.52M | ||
| Property, Plant & Equipment Net | 342.28K | ||
| Total Assets | 58.86M | ||
| Debt Current | 160.06K | ||
| Total Debt | 282.42K | ||
| Current Liabilities | 6.53M | ||
| Debt Non-Current | 122.37K | ||
| Total Liabilities | 6.66M | ||
| Accumulated Retained Earnings (Deficit) | -139.58M | ||
| Shareholders Equity | 52.20M | ||
| Shareholders Equity (USD) | 52.20M | ||
| Assets Non-Current | 342.28K | ||
| Total Debt (USD) | 282.42K | ||
| Liabilities Non-Current | 122.37K | ||
| Trade and Non-Trade Payables | 2.47M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 36.10K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -11.47M | ||
| Capital Expenditure | -37.26K | ||
| Net Cash Flow from Investing | -37.26K | ||
| Net Cash Flow from Operations | -11.43M | ||
| Share Based Compensation | 409.22K | ||